International Approvals for Guselkumab & Anakinra; Plus Adalimumab Biosimilar in Europe Michele B. Kaufman, PharmD, BCGP | April 30, 2018In Japan the use of guselkumab to treat erythrodermic, plaque and pustular psoriasis is approved, and anakinra is now indicated for Still’s disease in the E.U…